Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Josh Lloyd-Jones

Josh Lloyd-Jones

Contact information


josh.lloyd-jones@well.ox.ac.uk

Research groups

Josh Lloyd-Jones

RESEARCH ASSISTANT

Josh is currently working as a Research Assistant in the Lang group at the Oxford-GSK-IMCM, where his research is focused on using Parkinson’s patient derived iPSCs to analyse the effects of targeting the transcription factor NRF2.

Josh completed his Ph.D. in 2025 at the Department of Life Sciences at the University of Bath, characterising the cytoplasmic role of the protein SNRNP70 in neurodevelopment in zebrafish. His research interests centre on the molecular mechanisms underpinning neurodegenerative disease, and he is passionate about the development of therapeutics and treatment. 

Recent publications